Welcome to LookChem.com Sign In|Join Free

CAS

  • or
3-(benzyloxymethyl)-1-[2,3,5-tri-O-(tert-butyldimethylsilyl)-β-D-ribo-pentofuranosyl]uracil is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1332758-04-9

Post Buying Request

1332758-04-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1332758-04-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1332758-04-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,3,2,7,5 and 8 respectively; the second part has 2 digits, 0 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 1332758-04:
(9*1)+(8*3)+(7*3)+(6*2)+(5*7)+(4*5)+(3*8)+(2*0)+(1*4)=149
149 % 10 = 9
So 1332758-04-9 is a valid CAS Registry Number.

1332758-04-9Relevant articles and documents

Total synthesis of pacidamycin D by Cu(I)-Catalyzed oxy enamide formation

Okamoto, Kazuya,Sakagami, Masahiro,Feng, Fei,Togame, Hiroko,Takemoto, Hiroshi,Ichikawa, Satoshi,Matsuda, Akira

supporting information; experimental part, p. 5240 - 5243 (2011/12/14)

The first total synthesis of pacidamycin D, which is expected to be a good candidate as an antibacterial agent against P. aeruginosa, is described. The key elements of our approach feature an efficient and stereocontrolled construction of the Z-oxyvinyl iodide and copper-catalyzed crosscoupling with the tetrapeptide carboxamide.

Stereoselective synthesis of uridine-derived nucleosyl amino acids

Spork, Anatol P.,Wiegmann, Daniel,Granitzka, Markus,Stalke, Dietmar,Ducho, Christian

experimental part, p. 10083 - 10098 (2012/02/05)

Novel hybrid structures of 5′-deoxyuridine and glycine were conceived and synthesized. Such nucleosyl amino acids (NAAs) represent simplified analogues of the core structure of muraymycin nucleoside antibiotics, making them useful synthetic building blocks for structure-activity relationship (SAR) studies. The key step of the developed synthetic route was the efficient and highly diastereose-lective asymmetric hydrogenation of didehydro amino acid precursors toward protected NAAs. It was anticipated that the synthesis of unprotected muraymycin derivatives via this route would require a suitable intermediate protecting group at the N-3 of the uracil base. After initial attempts using PMB- and BOM-N-3 protection, both of which resulted in problematic deprotection steps, an N-3 protecting group-free route was envisaged. In spite of the pronounced acidity of the uracil-3-NH, this route worked equally efficient and with identical stereoselectivities as the initial strategies involving N-3 protection. The obtained NAA building blocks were employed for the synthesis of truncated 5′-deoxymuraymycin analogues (Figure presented).

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1332758-04-9